Clinical Trials

Blaze is focused on guided therapies and is working to develop Tumor Paint products and Optide-based guided therapeutics. Our first Tumor Paint product candidate, BLZ-100, is being developed for cancer surgery in brain and breast cancer. Below is a list of our currently open clinical trials for BLZ-100.
​
BLZ-100: Pediatric brain cancer (U.S.)
Title: A Phase 1 Dose-escalation and Expansion Study of BLZ-100 in Pediatric Subjects with Primary Central Nervous System Tumors
Objective: Evaluate the clinical safety of BLZ-100 in pediatric patients with primary central nervous system tumors
Status: Enrolling patients
More information: For a link to the clinicaltrials.gov site, please click here.


BLZ-100: Breast cancer (U.S.)
Title: A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Solid Tumors Undergoing Surgery
Objective: Evaluate the clinical safety of BLZ-100 in adult patients with breast cancer undergoing surgery
Status: Completed
More information: For a link to the clinicaltrials.gov site, please click here.